Follow the Pundits
Tag: hedge funds
Inside Citadel’s $170B+ 13F: How Ken Griffin Manages Thousands of Positions Without Betting the Farm
Citadel’s portfolio isn’t really a stock portfolio—it’s a risk machine. We unpack Ken Griffin’s latest 13F, its thousands of positions, huge index exposure, mega-cap holdings, options maze and the lessons retail investors can actually steal.
🎸 Michael Burry After Scion: His AI Short, 2027 Puts & New Value Picks 🐻📊
Michael Burry has moved beyond Scion Asset Management—but certainly not beyond contrarian investing. The Big Short investor is challenging the AI and semiconductor boom while simultaneously buying beaten-down companies including MercadoLibre, Birkenstock, Sprouts, QXO and Build-A-Bear. We examine his long-dated put strategy, current value picks, legendary research process—and the timing risk behind the Cassandra mystique.
🌲 Lone Pine Capital: Inside Steve Mandel’s $25B Tiger Cub Masterclass (+43% Surge in 1H 2026) 🏹
Steve Mandel’s Lone Pine Capital surged 43% in the first half of 2026. We dig into the $25B+ Tiger Cub’s Q2 portfolio, Nebius and Home Depot bets, long-term record, management obsession—and why “duration” may be its most important edge.
🚗 Group 1 Automotive (GPI): A $40.6M Hedge Fund Buy, 6× Forward P/E—and the Car Loan Crunch
Group 1 Automotive has fallen roughly 41% from its peak, earnings are weakening and auto affordability is under pressure. Yet Conifer Management just bought another $40.6 million of GPI near $290. With the stock around 6× forward earnings, a powerful service business and a $1.7 billion Hennessy expansion ahead, is this falling knife becoming a bargain?
🏒 Glenview Capital & Larry Robbins: The $5.5B “Hockey Jersey” Hedge Fund Slashing Wall Street 🏥⚡
Larry Robbins has built Glenview Capital around fundamental research, concentrated conviction and an unusual willingness to act like an owner. We examine its ~$5.5B Q2 2026 portfolio, CVS activism, healthcare bets, extraordinary early track record—and why hockey may explain more about Robbins than you'd expect. 🏒
⚾ Steve Cohen's Point72: Inside the $58.5B Alpha Factory, "Hogwarts" for Analysts, and the $3.4B Payday 💰📈
Steve Cohen didn't simply build another hedge fund.
He engineered an institutional investment machine.
Discover how Point72's Academy, 200+ autonomous investment pods, Cubist quantitative platform, and disciplined organizational design transformed it into one of Wall Street's most formidable alpha factories.
🏛️ Mario Gabelli & GAMCO Investors: Inside the 14.1% Compounding Machine, PMV Investing, and the $11.2 Billion Value Vault
Mario Gabelli transformed value investing by asking a different question: What would an informed buyer pay for the entire business? We explore the PMV framework, the Catalyst™ strategy, GAMCO's $36.6 billion asset base, 1,019-stock portfolio, and nearly five decades of compounding.
🏰 Howard Marks & Oaktree Capital: The Art of Second-Level Thinking and Risk-Control Investing
Howard Marks didn't build one of the world's greatest alternative investment firms by predicting markets—he built it by mastering risk. Explore Oaktree Capital's $224 billion empire, Second-Level Thinking, distressed investing, and the philosophy behind one of Wall Street's most respected investors.
🃏 David Einhorn & Greenlight Capital: Inside the Poker-Playing Short-Slayer's $3.2B Value Engine
David Einhorn didn't become famous by following Wall Street—he became famous by questioning it. From exposing Lehman Brothers to building Greenlight Capital into a legendary value-investing firm, here's what investors can learn from one of finance's sharpest independent thinkers.
🏔️ Li Lu & Himalaya Capital: The Art of Doing Nothing Exceptionally Well
Charlie Munger rarely trusted outside investors. Li Lu was the exception. Discover how Himalaya Capital compounded wealth through patience, concentration, and owning exceptional businesses for years—not quarters.